S&P 500 Industrials Sector SEC Filings — January 29, 2026

30-01-2026

Gentex Corp filed an 8-K on January 30, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing details. This appears to be an earnings-related disclosure with no quantified metrics available.

30-01-2026

ArcBest Corp /DE/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008222, Size: 16 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·File size: 16 MB

30-01-2026

NorthEast Community Bancorp, Inc./MD/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008167), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure typically associated with quarterly or annual financial results announcement.

30-01-2026

Verizon Communications Inc. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This multi-item filing pertains to financial results with no specific revenue, earnings, guidance, or period-over-period comparisons detailed in the provided information. No quantitative metrics, positive or negative performance indicators, or balance sheet effects are disclosed.

30-01-2026

Regeneron Pharmaceuticals, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0000872589-26-000004, Size: 735 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

30-01-2026

BCB BANCORP INC filed an 8-K on 2026-01-30 (AccNo: 0001193125-26-031836) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results disclosure, likely including a press release or earnings exhibits. No specific revenue, earnings, margins, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.

30-01-2026

SunPower Inc. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics, period-over-period changes, or strategic context were disclosed.

30-01-2026

Flagstar Bank, National Association filed a Form 8-K on January 30, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

30-01-2026

Brand Engagement Network Inc. filed a multi-item 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with additional other events under Item 8.01. While the material agreement may signal strategic funding or partnership opportunities, the new financial obligation introduces potential debt risks and the equity sales raise shareholder dilution concerns. No quantitative details such as transaction values, share counts, or financial impacts were disclosed.

30-01-2026

Mechanics Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative performance indicators were mentioned.

30-01-2026

FIRST NORTHERN COMMUNITY BANCORP filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, or other quantitative metrics are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period comparisons, or guidance revisions are detailed.

30-01-2026

LyondellBasell Industries N.V. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This represents a standard earnings announcement filing with no disclosed directional performance indicators.

30-01-2026

Designer Brands Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing information. No financial metrics, performance comparisons, or other impacts are mentioned.

30-01-2026

Church & Dwight Co Inc /DE/ filed an 8-K on 2026-01-30 reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data were explicitly disclosed in the provided filing information. Sector details were not specified.

30-01-2026

Atlantic Union Bankshares Corp filed a Form 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure likely including attached materials such as a press release or investor presentation. No financial metrics, transactions, guidance, or other quantitative details are specified in the filing information provided.

30-01-2026

Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

30-01-2026

Sierra Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of any exhibits are disclosed in the filing summary. This multi-item filing provides no quantitative metrics, financial impacts, or directional information.

30-01-2026

Alpha Metallurgical Resources, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance details are disclosed in the provided filing information.

30-01-2026

Republic Bancorp Inc./KY/ filed an 8-K on January 30, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a standard financial results disclosure with no directional performance indicators available.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, or specific impacts are provided in the filing summary.

30-01-2026

Edible Garden AG Inc filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000522), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates governance and shareholder rights changes, but specific details on modifications, amendments, events, or exhibits are NOT_DISCLOSED. No quantitative financial impacts, positive or negative metrics, or directional biases are provided.

30-01-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events (Accession No. 0001193125-26-030590, file size 155 KB). No specific details regarding the nature of the other event, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

30-01-2026

RED RIVER BANCSHARES INC filed an 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information.

30-01-2026

GLOBAL PARTNERS LP filed a Form 8-K on January 30, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance, with exhibits attached.

30-01-2026

Lottery.com Inc. filed a Form 8-K on January 30, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits, likely including the relevant documents. No specific details, quantitative impacts, positive or negative metrics, or directional changes are provided in the filing summary.

30-01-2026

Janus Henderson Group PLC filed an 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics available.

30-01-2026

Security Federal Corp filed an 8-K on January 30, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics are mentioned. No positive, negative, or flat performance indicators are provided.

30-01-2026

MetroCity Bankshares, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative financial metrics, period-over-period comparisons, or guidance are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

30-01-2026

OptimumBank Holdings, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate actions, but lacks quantitative data for assessment.

30-01-2026

SOURCE CAPITAL /DE/ filed an 8-K on January 30, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.

30-01-2026

Hypha Labs, Inc. filed an 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01. The filing also references financial statements and exhibits under Item 9.01. No additional quantitative data, reasons for the change, financial impacts, or other metrics are explicitly stated.

30-01-2026

Cullen/Frost Bankers, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed in the provided filing summary.

30-01-2026

International Endeavors Corp filed a Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Tevogen Bio Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004461, size 277 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, such as a press release. No quantitative metrics, transactions, or performance data—positive, negative, or flat—are disclosed in the filing summary.

30-01-2026

Mondelez International, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative impacts were disclosed.

30-01-2026

Surrozen, Inc./DE filed an 8-K on 2026-01-30 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, names, reasons, timing, or financial terms are provided in the filing summary. Sector not specified.

30-01-2026

Olema Pharmaceuticals, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details such as the affected officer's name, position, whether it was an appointment or resignation, reasons, or effective date are NOT_DISCLOSED.

30-01-2026

Blue Foundry Bancorp filed a Form 8-K on January 30, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details regarding the matters submitted, meeting date, proposals, vote outcomes, or tallies are disclosed in the available filing summary. This represents a standard mandatory disclosure for shareholder voting results.

30-01-2026

Genasys Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or additional context provided.

30-01-2026

Design Therapeutics, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031772), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector is NOT_DISCLOSED.

30-01-2026

SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on January 30, 2026 (AccNo: 0001731122-26-000156, Size: 187 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, dollar amounts, or parties involved are disclosed in the available filing information. This is a single-item mandatory disclosure typically related to exempt equity issuances under the Securities Act.

30-01-2026

Generation Income Properties, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, balance sheet effects, or guidance changes are disclosed.

30-01-2026

PEDEVCO CORP filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or compensation arrangements are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

30-01-2026

Archimedes Tech SPAC Partners III Co. filed an 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or scheduled events are mentioned.

30-01-2026

NEW PEOPLES BANKSHARES INC filed an 8-K on January 30, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure for the company in the US market. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed.

30-01-2026

FIRST ADVANTAGE CORP filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031830, Size: 150 KB), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. Sector is not specified.

30-01-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events). No specific details of the event, financial metrics, transaction values, or impacts are disclosed in the provided filing information. No positive or negative developments, period-over-period comparisons, or scheduled events are mentioned.

• ·AccNo: 0001193125-26-031818
• ·Filing Size: 145 KB
• ·Event Type: General Filing
• ·Sector: NOT_DISCLOSED

30-01-2026

Pioneer Bancorp, Inc./MD filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the filing summary. This represents a standard voluntary earnings-related disclosure with attached exhibits.

30-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-010254), disclosing an other event under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on parties, deal structure, valuation, financial metrics, synergies, regulatory pathway, or shareholder impacts are provided. Sector is not specified, and no quantitative data or scheduled events are mentioned.

• ·File size: 266 KB

30-01-2026

CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031802, Size: 172 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information voluntarily to comply with Regulation FD, with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the filing summary. No quantitative data or performance metrics (positive, negative, or flat) are mentioned.

30-01-2026

Federated Hermes, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of any attached financial statements or exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantified financial metrics, positive or negative changes, or directional impacts mentioned.

30-01-2026

IF Bancorp, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides disclosure of financial results but no specific metrics, comparisons, or performance details are stated in the provided information. No positive, negative, or flat metrics are disclosed.

30-01-2026

Quetta Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a new material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, signaling a pivot in merger/acquisition strategy. No quantitative metrics, deal values, parties involved, or financial impacts are disclosed, resulting in mixed implications with no clear positive or negative dominance. Sector details are not specified.

30-01-2026

Legato Merger Corp. IV filed an 8-K on 2026-01-30 (AccNo: 0001829126-26-000821) disclosing Item 3.02 Unregistered Sales of Equity Securities, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts are mentioned. Sector is not specified, and no quantitative data or comparisons are provided.

30-01-2026

Carter Bankshares, Inc. filed an 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached supporting documents. No specific financial metrics, transactions, or quantitative data are disclosed.

30-01-2026

AGCO Corp filed an 8-K on January 30, 2026, reporting solely under Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the financial statements, exhibits, transactions, metrics, or events are disclosed in the provided filing information. This is an informational exhibit attachment with no quantitative data or directional implications provided.

30-01-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01 and other events under Item 8.01. No financial metrics, transaction values, period-over-period comparisons, or impacts are mentioned. This is a multi-item filing with no quantified positive or negative details provided.

30-01-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004543), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This constitutes a multi-item mandatory disclosure with no quantitative details on transaction values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

30-01-2026

NEXGEL, INC. filed an 8-K on 2026-01-30 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or compensation are disclosed.

30-01-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details, financial terms, impacts, or quantitative metrics are disclosed in the provided filing summary.

30-01-2026

30-01-2026

urban-gro, Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, alongside Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on positions affected, reasons for changes, vote outcomes, or exhibit contents are disclosed. No quantitative financial metrics, performance comparisons, or directional indicators provided.

30-01-2026

Abacus Global Management, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004416, Size: 216 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific events, transactions, financial metrics, or performance data disclosed in the provided information. No positive or negative metrics are mentioned.

30-01-2026

Luminar Technologies, Inc./DE filed an 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material information to ensure broad dissemination under Regulation FD, with attached exhibits. No specific financial metrics, transactions, events, or performance details are explicitly stated in the filing metadata.

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.